About: Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing
Creator	Petersen, Eskild Zumla, Alimuddin
Source	Elsevier; Medline; PMC
abstract	covid:36c569ba503a47de5561d8e0f29ca6efb07b3e0b#abstract
has issue date	2020-08-19(xsd:dateTime)
bibo:doi	10.1016/j.ijid.2020.08.043
bibo:pmid	32822866
has license	no-cc
sha1sum (hex)	36c569ba503a47de5561d8e0f29ca6efb07b3e0b
schema:url	https://doi.org/10.1016/j.ijid.2020.08.043
resource representing a document's title	Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing
has PubMed Central identifier	PMC7435296
has PubMed identifier	32822866
schema:publication	Int J Infect Dis
resource representing a document's body	covid:36c569ba503a47de5561d8e0f29ca6efb07b3e0b#body_text
is schema:about of	named entity 'transparent' named entity 'standards' named entity 'fastrack' named entity 'ONLINE' named entity 'SAFETY' named entity 'Professor' named entity 'safety' named entity 'vaccines' named entity 'coronavirus vaccine' named entity 'gold standard' named entity 'Microbiology' named entity 'immunogenic' named entity 'phase 1' named entity 'Ebola' named entity 'SARS' named entity 'vaccine' named entity 'China' named entity 'vaccine' named entity 'COVID' named entity 'WHO' named entity 'developed countries' named entity 'FDA' named entity 'Mexico' named entity 'phase three trial' named entity 'adverse reactions' named entity 'immunogenicity' named entity 'R&D' named entity 'vaccine' named entity 'approval process' named entity 'vaccine' named entity 'vaccine' named entity 'COVID' named entity 'WHO' named entity 'SARS-CoV-2' named entity 'virus' named entity 'August 10' named entity 'COVID-19' named entity 'WHO' named entity 'COVID-19' named entity 'vaccine' named entity 'phase III' named entity 'vaccine' named entity 'vaccine' named entity 'vaccine' named entity 'WHO' named entity 'Washington Post' named entity 'immunocompetent' named entity 'phase 3 trial' named entity 'western countries' named entity 'EMA' named entity 'COVID-19 pandemic' named entity 'developing countries' named entity 'vaccination' named entity 'phase 3 trial' named entity 'vaccine' named entity 'multiplier effect' named entity 'genetic sequences' named entity 'western countries' named entity 'COVID vaccine' named entity 'pre-clinical' named entity 'western countries' named entity 'phase 2' named entity 'MERS-CoV' named entity 'adenovirus' named entity 'Brazil' named entity 'EMA' named entity 'FDA' named entity 'phase 1' named entity 'MERS-CoV' named entity 'Moscow' named entity 'FDA' named entity 'SARS-CoV-1' named entity 'Germany' named entity 'Russia' named entity 'vaccine' named entity 'vaccine' named entity 'immunogenicity' named entity 'SARS-CoV-2' named entity 'vaccine' named entity 'vaccine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software